Cefuroxime
- Generic Name
- Cefuroxime
- Brand Names
- Ceftin
- Drug Type
- Small Molecule
- Chemical Formula
- C16H16N4O8S
- CAS Number
- 55268-75-2
- Unique Ingredient Identifier
- O1R9FJ93ED
- Background
Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, gonorrhea, and haemophilus.
- Indication
For the treatment of many different types of bacterial infections such as bronchitis, sinusitis, tonsillitis, ear infections, skin infections, gonorrhea, and urinary tract infections.
- Associated Conditions
- Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB), Animal bite, Bacterial Infections, Bone and Joint Infections, Impetigo, Lower Respiratory Tract Infection (LRTI), Lyme Disease, Maxillary Sinusitis, Meningitis, Neisseria Gonorrhoeae Infection, Septicemia, Skin and Subcutaneous Tissue Bacterial Infections, Urinary Tract Infection, Bacterial otitis media, Mild Streptococcal pharyngitis, Mild Streptococcal tonsillitis, Moderate Streptococcal pharyngitis, Moderate Streptococcal tonsillitis
- Associated Therapies
- -
Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis
- Conditions
- Interventions
- First Posted Date
- 2024-11-29
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Rigshospitalet, Denmark
- Target Recruit Count
- 248
- Registration Number
- NCT06709196
- Locations
- 🇩🇰
Department of Urology, Aalborg University Hospital, Aalborg, Denmark
🇩🇰Department of Urology, Aarhus University Hospital, Aarhus, Denmark
🇩🇰Department of Urology, Rigshospitalet, Copenhagen, Denmark
Clinical Trial Comparing Oral Versus Intravenous Cefuroxime in Pregnant Women With Pyelonephritis
- Conditions
- Interventions
- First Posted Date
- 2024-07-30
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- Hospital de Clinicas de Porto Alegre
- Target Recruit Count
- 100
- Registration Number
- NCT06527560
- Locations
- 🇧🇷
HCPA, Porto Alegre, RS, Brazil
Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW)
- First Posted Date
- 2023-03-24
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Leiden University Medical Center
- Target Recruit Count
- 344
- Registration Number
- NCT05784311
- Locations
- 🇳🇱
Leiden University Medical Center, Leiden, Zuid Holland, Netherlands
🇳🇱Amsterdam University Medical Center, Amsterdam, Netherlands
🇳🇱Amphia Ziekenhuis, Breda, Netherlands
Colo-Pro_2: Bolus-continuous Infusion Cefuroxime Prophylaxis for the Prevention of Infections After Colorectal Surgery
- First Posted Date
- 2022-11-08
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University of Leeds
- Target Recruit Count
- 180
- Registration Number
- NCT05609240
- Locations
- 🇬🇧
TheUniversity of Birmingham, Birmingham, West Midlands, United Kingdom
🇬🇧Aneurin Bevan University Health Board, Newport, United Kingdom
🇬🇧Leeds Teaching Hospitals, Leeds, West Yorkshire, United Kingdom
Population Pharmacokinetics, Effectiveness and Safety of Cefuroxime in Neonates
- Conditions
- First Posted Date
- 2022-05-24
- Last Posted Date
- 2022-05-24
- Lead Sponsor
- Shandong University
- Target Recruit Count
- 100
- Registration Number
- NCT05388747
- Locations
- 🇨🇳
Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, Tianjin, China
Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection
- Conditions
- Interventions
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2022-11-15
- Lead Sponsor
- Zhong Wang
- Target Recruit Count
- 60
- Registration Number
- NCT04479657
- Locations
- 🇨🇳
Dongfang Hospital, Beijing, Beijing, China
Pharmacokinetics of Amikacin and Cefuroxime in Critically Ill Patients.
- Conditions
- Interventions
- First Posted Date
- 2020-07-14
- Last Posted Date
- 2022-09-10
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT04470973
- Locations
- 🇳🇱
Radboudumc intensive care, Nijmegen, Netherlands
24 Vs 48 Hours of Cefazolin or Cefuroxime as Prophylaxis
- Conditions
- Interventions
- First Posted Date
- 2020-03-11
- Last Posted Date
- 2023-04-11
- Lead Sponsor
- Saud Al Babtain Cardiac Center
- Target Recruit Count
- 568
- Registration Number
- NCT04303390
- Locations
- 🇸🇦
Saud AlBabtain Cardiac Center, Dammam, Eastern Province, Saudi Arabia
Intracameral Levofloxacin (0.5%) vs Intracameral Cefuroxime
- Conditions
- Interventions
- First Posted Date
- 2019-12-26
- Last Posted Date
- 2020-09-21
- Lead Sponsor
- National University of Malaysia
- Target Recruit Count
- 138
- Registration Number
- NCT04212078
- Locations
- 🇲🇾
UKM Medical Centre, Kuala Lumpur, Wilayah Persekutuan, Malaysia
Pharmacokinetics of Post Operative Cefuroxime in Infants Undergoing Cardiac Surgery
- Conditions
- First Posted Date
- 2016-07-29
- Last Posted Date
- 2019-01-10
- Lead Sponsor
- Alder Hey Children's NHS Foundation Trust
- Registration Number
- NCT02850250
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.